QT interval prolongation: clinical assessment, risk factors and quantitative pharmacological considerations
Crossref DOI link: https://doi.org/10.1007/s10928-025-10010-x
Published Online: 2025-11-07
Published Print: 2025-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gotta, Verena
Donner, Birgit
Funding for this research was provided by:
University of Basel
Text and Data Mining valid from 2025-11-07
Version of Record valid from 2025-11-07
Article History
Received: 8 July 2025
Accepted: 24 October 2025
First Online: 7 November 2025
Declarations
:
: The authors declare no competing interests.